BRAF Videos

Monica Niger, MD, National Cancer Institute - MIlan

Videos

Clinical Relevance of BRAF Alterations in Biliary Tract Cancers

08/22/2023

At the 2023 World Congress on Gastrointestinal Cancers, Monica Niger, MD, discusses the clinical relevance and actionability of BRAF alterations among patients with advanced biliary tract cancers.

At the 2023 World Congress on...

08/22/2023

Oncology

Yu Sunakawa, MD, St. Marianna University School of Medicine

Videos

Modified FOLFOXIRI Plus Cetuximab as the First-Line Treatment for Patients With RAS Wild-Type Metastatic Colorectal Cancer

07/28/2023

Yu Sunakawa , MD;

At the 2023 ESMO World Congress on Gastrointestinal Cancers, Yu Sunakawa, MD, presented updated survival data from the phase 2 DEEPER trial, evaluating modified(m)-FOLFOXIRI plus cetuximab vs m-FOLFOXIRI plus bevacizumab among patients with...

At the 2023 ESMO World Congress...

07/28/2023

Oncology

Understanding Metastatic MSI-High and MS-Stable Colorectal Cancer

Sponsored

Videos

Understanding Metastatic MSI-High and MS-Stable Colorectal Cancer

03/03/2021

Michael Morse, MD, FACP, MHS, discusses the role that microsatellite stability (MSS) or microsatellite instability (MSI) plays in metastatic CRC.

Michael Morse, MD, FACP, MHS,...

03/03/2021

Oncology

Genomic Features of BRAF and Its Role in the RAS/MAPK Pathway in Colorectal Cancer

Sponsored

Videos

Genomic Features of BRAF and Its Role in the RAS/MAPK Pathway in Colorectal Cancer

03/03/2021

Ryan Corcoran, MD, PhD, discusses the characterization of BRAF mutations and the evolving treatment landscape for patients with BRAF/RAS mutations.

Ryan Corcoran, MD, PhD,...

03/03/2021

Oncology

Exploring HER2 in Metastatic Colorectal Cancer

Sponsored

Videos

Exploring HER2 in Metastatic Colorectal Cancer

02/19/2021

In this video, Christina Wu, MD, discusses HER2 in patients with metastatic CRC.

In this video, Christina Wu, MD,...

02/19/2021

Oncology

The Importance of Biomarker Testing: Carrying Out the Testing Process

Sponsored

Videos

The Importance of Biomarker Testing: Carrying Out the Testing Process

02/19/2021

In part 3 of this video series, Marwan Fakih, MD, discusses how oncologists can make the biomarker testing process understandable for patients with metastatic CRC.

In part 3 of this video series,...

02/19/2021

Oncology

The Importance of Biomarker Testing: Testing Strategies

Sponsored

Videos

The Importance of Biomarker Testing: Testing Strategies

02/19/2021

In part 2 of this video series, Marwan Fakih, MD, discusses testing strategies for detecting mutations in patients with metastatic CRC.

In part 2 of this video series,...

02/19/2021

Oncology

The Importance of Biomarker Testing: Prognostic and Predictive Biomarkers

Sponsored

Videos

The Importance of Biomarker Testing: Prognostic and Predictive Biomarkers

02/17/2021

In part 1 of this video series, Marwan G. Fakih, MD, discusses the role prognostic and predictive biomarkers play in metastatic colorectal cancer.

In part 1 of this video series,...

02/17/2021

Oncology

Videos

Deep Sequencing Impacts Treatment Landscape for MM

01/03/2020

Gareth Morgan, MD, PhD, discusses deep sequencing and how it is improving the treatment landscape for MM.

Gareth Morgan, MD, PhD,...

01/03/2020

Oncology

Videos

Managing Resistance to Third-Generation TKIs in NSCLC

11/22/2019

Lyudmila Bazhenova, MD, talks about understanding, preventing, and delaying EGFR-resistance in the era of osimertinib therapy.

Lyudmila Bazhenova, MD, talks...

11/22/2019

Oncology

Recent News

News

Intraoperative Radiation Therapy May Improve Survival For Certain Patients With Recurrent Cervical or Endometrial Cancer

11/14/2024

Allison Casey ;

According to a retrospective study, there was an appreciable survival gain for well-selected patients with recurrent or persistent endometrial or cervical cancer who receive intraoperative radiation therapy.

According to a retrospective...

11/14/2024

Oncology

News

Amrubicin Plus Irinotecan Demonstrates Promising Efficacy, Safety for Chemotherapy-Naïve Patients With Extensive-Disease Small Cell Lung Cancer

11/14/2024

Stephanie Holland ;

According to results from the phase 2 LC 08-01 trial, amrubicin plus irinotecan demonstrated promising efficacy and safety among chemotherapy-naïve patients with extensive-disease small cell lung cancer.

According to results from the...

11/14/2024

Oncology

News

Addition of Bempegaldesleukin to Nivolumab Does Not Benefit Cisplatin-Ineligible Patients With First-Line Advanced Urothelial Carcinoma

11/13/2024

Stephanie Holland ;

Results from the phase 2 PIVOT-10 trial demonstrated that the addition of bempegaldesleukin to first-line nivolumab did not improve outcomes for cisplatin-ineligible patients with locally advanced or metastatic urothelial carcinoma.

Results from the phase 2...

11/13/2024

Oncology

News

Mirdametinib for Adult and Pediatric Patients With Neurofibromatosis Type 1 With Plexiform Neurofibromas

11/12/2024

Allison Casey ;

According to a phase 2b trial, mirdametinib demonstrated significant confirmed objective response rates with deep and durable reductions of volume of target plexiform neurofibromas and clinically meaningful improvements to health-related...

According to a phase 2b trial,...

11/12/2024

Oncology

News

Epirubicin Plus Cyclophosphamide and Docetaxel Reduces Long-Term Risk of Recurrence for Patients With TOP2A Normal Early Breast Cancer

11/12/2024

Stephanie Holland ;

According to final results from the DBCG 07-READ trial, the addition of epirubicin to cyclophosphamide and docetaxel reduced long-term risk of breast cancer recurrence among patients with TOP2A normal early breast cancer.

According to final results from...

11/12/2024

Oncology

News

Pembrolizumab Plus Chemotherapy For Patients With High-Risk Endometrial Cancer

11/11/2024

Allison Casey ;

According to results from a phase 3 trial, pembrolizumab plus chemotherapy did not improve DFS among patients with high-risk endometrial cancer. However, there may be a benefit among patients with mismatch report-deficient disease.

According to results from a...

11/11/2024

Oncology

FDA Approval

FDA Grants Approval to Obecabtagene Autoleucel for R/R B-Cell Precursor Acute Lymphoblastic Leukemia

11/08/2024

On November 8, 2024, the FDA approved CD19-directed genetically modified autologous T cell immunotherapy obecabtagene autoleucel for the treatment of patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

On November 8, 2024, the FDA...

11/08/2024

Oncology

News

Naporafenib in Combination With Rineterkib or Tremetinib for KRAS- or BRAF-Mutant Non-Small Cell Lung Cancer

11/07/2024

Allison Casey ;

While naporafenib plus rineterkib and naporafenib plus trametinib both had acceptable safety profiles, antitumor activity was limited among patients with KRAS-/BRAF-mutant non-small cell lung cancer.

While naporafenib plus...

11/07/2024

Oncology

News

Addition of Concurrent Thoracic Radiotherapy to First-Line TKI Therapy Improves Survival for Patients With EGFR-Mutated Non-Small Cell Lung Cancer

11/06/2024

Stephanie Holland ;

According to results from a phase 3 trial, the addition of concurrent thoracic radiotherapy to first-line icotinib improved survival among patients with EGFR-mutated oligo-organ metastatic non-small cell lung cancer.

According to results from a...

11/06/2024

Oncology

News

Ipilimumab After PD-1 Inhibition Failure Among Patients With Metastatic Melanoma

11/05/2024

Allison Casey ;

A single-center real-world study found the use of ipilimumab in the second-line was an effective therapy for patients with metastatic BRAF/NRAS-wildtype metastatic melanoma without brain metastases.

A single-center real-world study...

11/05/2024

Oncology